Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?

Nature Clinical Practice Cardiovascular Medicine volume 1, pages 16–17 (2004)Cite this article

boxed-textKadish A et al. (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350: 2151–2158

Prophylactic ICD placement appears as beneficial in patients with heart failure and severe left-ventricular dysfunction due to nonischemic cardiomyopathy as in patients with ischemic cardiomyopathy

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Domanski M et al. (1997) Treatment of sudden cardiac death. Current understandings from randomized trials and future research directions Circulation 95: 2694–2699

    Article  CAS  Google Scholar 

  2. Buxton A et al. (1999) A randomized study of the prevention of sudden cardiac death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators New Engl J Med 341: 1881–1890

    Article  Google Scholar 

  3. Moss AJ et al. (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implanation Trial Investigators New Engl J Med 335: 1933–1940

    Article  CAS  Google Scholar 

  4. Bardy G (In press) Am Coll Cardiol Annual Scientific Sessions New Orleans, LA

  5. Zipes D (2001) Implantable cardioverter-defibrillator: a Volkswagen or a Rolls Royce: How much will we pay to save a life? Circulation 105: 1453–1458

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Ruth Kirby, Research Highlights Editor, Nature Clinical Practice.

Author information

Author notes

  1. His interests include the history and therapy of acute and chronic hypertrophic coronary artery disease, electrophysiology, adult congenital heart disease, the cardiomyopathies with and the clinical implications of molecular genetics.

Authors and Affiliations

  1. Professor of Medicine, Mayo Clinic College of Medicine,

    Bernard Gersh

Authors
  1. Bernard Gersh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernard Gersh.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gersh, B. Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?. Nat Rev Cardiol 1, 16–17 (2004). https://doi.org/10.1038/ncpcardio0014

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0014

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing